Researchers should consider whether a peptide mechanism of action could theoretically worsen the specific immune pathways that are already overactive in SLE
The ranges below reflect what's most frequently cited across non-clinical, anecdotal, and vendor-reported protocols, not a recommendation from PepGuard or a clinician
Patient Selection for Combination Therapy Choosing who gets combination therapy with Tiaminal B12 is detailed
Unlike classical neurotransmitters, its not definitively produced within neurons, lacks confirmed precursor molecules in neural tissue, and has no conclusively demonstrated direct receptor binding
Over time, that interest expanded into other areas, including muscle, tendon, ligament, and soft-tissue healing
Confirm the labeled vial size before doing any concentration math